Geneos Wealth Management Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$7,359
-12.7%
195
+5.4%
0.00%
Q2 2023$8,429
+12.3%
1850.0%0.00%
Q1 2023$7,504
+601.3%
185
+781.0%
0.00%
Q4 2022$1,07021
+23.5%
0.00%
Q3 2022$0
-100.0%
17
-99.4%
0.00%
-100.0%
Q2 2022$175,000
-16.7%
2,680
-1.4%
0.01%0.0%
Q1 2022$210,000
-33.1%
2,717
-25.7%
0.01%
-25.0%
Q4 2021$314,000
+29.8%
3,658
+22.7%
0.01%
+33.3%
Q3 2021$242,000
+2.1%
2,981
+2.7%
0.01%0.0%
Q2 2021$237,000
-13.5%
2,902
-9.4%
0.01%
+12.5%
Q1 2021$274,000
+10.5%
3,2040.0%0.01%
-20.0%
Q4 2020$248,000
-5.7%
3,204
-3.2%
0.01%
-28.6%
Q3 2020$263,000
-28.9%
3,311
-24.7%
0.01%
-33.3%
Q2 2020$370,000
+10.8%
4,395
+4.8%
0.02%
-4.5%
Q1 2020$334,000
+21.5%
4,195
+28.1%
0.02%
+46.7%
Q4 2019$275,000
-2.1%
3,2750.0%0.02%
-11.8%
Q3 2019$281,000
+2.6%
3,275
-2.2%
0.02%0.0%
Q2 2019$274,000
+0.7%
3,3490.0%0.02%
-5.6%
Q1 2019$272,000
-30.3%
3,349
-44.1%
0.02%
-37.9%
Q4 2018$390,000
+68.1%
5,986
+98.5%
0.03%
+93.3%
Q3 2018$232,000
+3.1%
3,015
-1.1%
0.02%
-16.7%
Q2 2018$225,000
+13.6%
3,0480.0%0.02%
+5.9%
Q1 2018$198,000
-3.9%
3,048
-4.7%
0.02%
-5.6%
Q4 2017$206,000
-2.8%
3,198
-5.6%
0.02%
-14.3%
Q3 2017$212,000
+3.4%
3,388
+0.0%
0.02%0.0%
Q2 2017$205,000
+20.6%
3,387
+3.1%
0.02%
+16.7%
Q1 2017$170,000
+14.1%
3,285
-2.8%
0.02%
-10.0%
Q4 2016$149,000
-28.7%
3,380
-23.3%
0.02%
-28.6%
Q3 2016$209,000
+8.3%
4,405
+3.7%
0.03%0.0%
Q2 2016$193,000
+7.8%
4,248
-1.1%
0.03%
+3.7%
Q1 2016$179,0004,2950.03%
Other shareholders
BAXTER INTL INC shareholders Q4 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders